Memory Loss: Clinical Trials

4 trials for Memory Loss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 11Completed 1

Follow Memory Loss: new trials by email Literature Review of Memory Loss trials Research Report on Memory Loss

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Social Support Aid For People With Dementia
Social Support Aid - Dementia, Memory Loss
Phase 2CompletedUniversity of Minnesota482016-11-012022-04-21
Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
ladostigil hemitartrate - Alzheimer's Disease, Dementia
Phase 2CompletedAvraham Pharmaceuticals Ltd2002011-02-012020-07-30
Aging and Estrogen on Cortical Function
Estradiol oral capsule, transderman estrogen patch, trasdermal placebo patch - Memory Loss, Cognitive Changes
Phase 1 / Phase 2CompletedMassachusetts General Hospital382009-11-012018-08-22
Phytoestrogens and Memory Decline in Menopause
Isoflavones - Memory Loss, Postmenopause
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)962002-12-012007-10-26

Narrower conditions

Memory Disorders (4)  ·  Dementia (2)  ·  Alzheimer Disease (1)  ·  Anxiety Disorders (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)

Broader conditions

Neurobehavioral Manifestations (4)  ·  Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Nervous System Diseases (3)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cognition Disorders (1)  ·  Mental Disorders (1)  ·  Neurocognitive Disorders (1)  ·  Tauopathies (1)

Interventions

Estradiol (1)  ·  Isoflavones (1)

Sponsors

Avraham Pharmaceuticals Ltd (1)  ·  Massachusetts General Hospital (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  University of Minnesota (1)

Countries

United States (2)  ·  Austria (1)  ·  Croatia (1)  ·  Germany (1)  ·  Serbia (1)  ·  Spain (1)

Top investigators

Janet E Hall, MD (1)  ·  Reinhold Schmidt, MD (1)  ·  Robert Krikorian, PhD (1)

Results publications

PMID 31518270

NIH funding

R01AG013241 (1), R44AG041667 (1)